GlassScriptPhysician profile
Daniel James Burgess
NPI 1861804247
$28,214.96
in general payments reported to CMS, 2019-2025
30 companies · $9,822 in 2025
The $9,822 reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $157 · 2021: $1,248 · 2022: $1,709 · 2023: $5,854 · 2024: $9,424 · 2025: $9,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Food and Beverage: $3,170 · Consulting Fee: $975 · Long Term Medical Supply Or Device Loan: $765 · Gift: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,000.00 |
| Food and Beverage | $3,169.61 |
| Consulting Fee | $975.00 |
| Long Term Medical Supply Or Device Loan | $765.33 |
| Gift | $190.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,179.44 | 2021-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $2,069.07 | 2021-2023 | |
| Axonics, INC. | $1,172.21 | 2021-2024 | Axonics |
| Integra Lifesciences Corporation | $808.18 | 2025 | Micromatrix, Integra, Primatrix |
| Takeda Pharmaceuticals U.S.A., INC. | $483.18 | 2021-2025 | Gattex |
| Daiichi Sankyo INC. | $474.49 | 2021-2025 | Injectafer |
| Mimedx Group, INC. | $424.00 | 2024-2025 | |
| Davol INC. | $287.44 | 2021-2025 | Phasix Mesh |
| Convatec INC. | $180.94 | 2020-2025 | |
| Kerecis Limited | $174.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Biotissue Holdings INC. | $154.31 | 2024-2025 | |
| Stryker Corporation | $136.25 | 2022 | |
| Boston Scientific Corporation | $133.94 | 2025 | Axonics, Spyglass Discover |
| Ethicon US, LLC | $88.87 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $59.45 | 2023-2024 | Exparel, Iovera |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $43.87 | 2021 | |
| Organogenesis INC. | $38.64 | 2023-2024 | Puraply |
| Activ Surgical, INC. | $36.28 | 2022 | |
| Acell, INC. | $34.07 | 2020 | |
| Braintree Laboratories, INC. | $32.66 | 2022-2023 | Sutab |
| Allergan, INC. | $29.16 | 2020 | |
| Reprise Biomedical, INC. | $23.59 | 2023 | Miro3d |
| La Jolla Pharmaceutical Company | $22.74 | 2021 | |
| Virtual Incision Corporation | $22.39 | 2025 | Mira |
| Covidien LP | $21.55 | 2020 | |
| 180 Medical, INC. | $20.77 | 2025 | |
| Aroa Biosurgery Incorporated | $18.51 | 2022 | |
| Angiodynamics, INC. | $18.06 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.01 | 2020 | |
| Baudax Bio INC. | $12.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Burgess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.